These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27182739)

  • 21. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
    Breitenecker K; Heiden D; Demmer T; Weber G; Primorac AM; Hedrich V; Ortmayr G; Gruenberger T; Starlinger P; Herndler-Brandstetter D; Barozzi I; Mikulits W
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
    Dunne PD; McArt DG; Blayney JK; Kalimutho M; Greer S; Wang T; Srivastava S; Ong CW; Arthur K; Loughrey M; Redmond K; Longley DB; Salto-Tellez M; Johnston PG; Van Schaeybroeck S
    Clin Cancer Res; 2014 Jan; 20(1):164-75. PubMed ID: 24170546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.
    Song X; Wang H; Logsdon CD; Rashid A; Fleming JB; Abbruzzese JL; Gomez HF; Evans DB; Wang H
    Cancer; 2011 Feb; 117(4):734-43. PubMed ID: 20922806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma.
    Zhou T; Gao Y
    World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.
    Zhang B; Dong LW; Tan YX; Zhang J; Pan YF; Yang C; Li MH; Ding ZW; Liu LJ; Jiang TY; Yang JH; Wang HY
    Br J Cancer; 2013 Jul; 109(1):14-23. PubMed ID: 23764751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.
    Reichl P; Dengler M; van Zijl F; Huber H; Führlinger G; Reichel C; Sieghart W; Peck-Radosavljevic M; Grubinger M; Mikulits W
    Hepatology; 2015 Mar; 61(3):930-41. PubMed ID: 25251599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma.
    Pinato DJ; Brown MW; Trousil S; Aboagye EO; Beaumont J; Zhang H; Coley HM; Mauri FA; Sharma R
    Br J Cancer; 2019 Mar; 120(5):512-521. PubMed ID: 30765873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy.
    Wubetu GY; Utsunomiya T; Ishikawa D; Yamada S; Ikemoto T; Morine Y; Iwahashi S; Saito Y; Arakawa Y; Imura S; Kanamoto M; Zhu C; Bando Y; Shimada M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S721-8. PubMed ID: 24965572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the receptor tyrosine kinase Axl in hepatocellular carcinoma and its clinical relevance.
    Niu ZS; Niu XJ; Wang WH
    Future Oncol; 2019 Feb; 15(6):653-662. PubMed ID: 30648886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
    Seike M; Kim CH; Zou F; Noro R; Chiba M; Ishikawa A; Κunugi S; Kubota K; Gemma A
    Oncol Rep; 2017 Jun; 37(6):3261-3269. PubMed ID: 28440492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
    Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
    Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy.
    Zhang D; Cao L; Li Y; Lu H; Yang X; Xue P
    World J Surg Oncol; 2013 Jan; 11():25. PubMed ID: 23356443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma.
    Wang W; Jia WD; Hu B; Pan YY
    Oncotarget; 2017 Apr; 8(16):26434-26447. PubMed ID: 28460436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy.
    Cheung ST; Ho JC; Leung KL; Chen X; Fong DY; So S; Fan ST
    Neoplasia; 2005 Feb; 7(2):91-8. PubMed ID: 15810144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.